Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Pérez-Garcia JM"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alés-Martínez JE; Hospital Nuestra Sra. De Sonsoles, Ávila, Spain. Electronic address: jealesm@seom.org., Balmaña J; Hospital Universitari Vall D'Hebron, Barcelona, Spain., Sánchez-Rovira P; Hospital Universitario de Jaén, Jaén, Spain., Salvador Bofill FJ; Hospital Universitario Virgen del Rocío, Sevilla, Spain., García Sáenz JÁ; Hospital Clínico San Carlos, Madrid, Spain., Pimentel I; Hospital Universitari Vall D'Hebron, Barcelona, Spain., Morales S; Hospital Universitario Arnau de Vilanova de Lleida, Lleida, Spain., Fernández-Abad M; Hospital Universitario Ramón y Cajal, Madrid, Spain; Universidad de Alcalá de Henares, Madrid, Spain., Lahuerta Martínez A; Onkologikoa, Gipuzkoa, Spain., Ferrer N; Hospital Universitari Son Espases, Illes Balears, Spain., Zamora P; Hospital Universitario de La Paz, Madrid, Spain., Bermejo B; Hospital Clínico Universitario de Valencia, Valencia, Spain., Díaz-Redondo T; Unidad de Gestión Clínica Intercentros de Oncología, Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Málaga, Spain., López-Ceballos MH; Hospital San Pedro de Alcántara, Cáceres, Spain., Galán M; Hospital Son Llàtzer, Palma de Mallorca, Spain., Pérez-Escuredo J; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City (New Jersey, USA), Sao Paulo, Brazil., Calabuig L; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City (New Jersey, USA), Sao Paulo, Brazil., Sampayo M; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City (New Jersey, USA), Sao Paulo, Brazil., Pérez-Garcia JM; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City (New Jersey, USA), Sao Paulo, Brazil; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain., Cortés J; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City (New Jersey, USA), Sao Paulo, Brazil; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain; IOB Madrid, Hospital Beata María Ana, Madrid, Spain., Llombart-Cussac A; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City (New Jersey, USA), Sao Paulo, Brazil; Hospital Arnau de Vilanova, FISABIO, Valencia, Spain; Universidad Católica de Valencia, Valencia, Spain.
Publikováno v:
Breast (Edinburgh, Scotland) [Breast] 2024 Oct; Vol. 77, pp. 103780. Date of Electronic Publication: 2024 Aug 02.
Autor:
Llombart-Cussac A; Hospital Arnau de Vilanova, Universidad Católica de Valencia, Valencia, Spain.; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Pérez-Garcia JM; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain., Ruiz Borrego M; Virgen del Rocío University Hospital, Sevilla, Spain., Tolosa P; 12 de Octubre University Hospital, Madrid, Spain., Blanch S; Instituto Valenciano de Oncologia, Valencia, Spain., Fernández-Ortega A; Catalan Institute of Oncology, Hospitalet, Spain., Urruticoechea A; Gipuzkoa Cancer Unit, OSID-Onkologikoa, San Sebastián, Spain., Blancas I; Hospital Universitario Clínico San Cecilio, Medicine Department, Medicine Faculty, Granada University, Instituto de Investigación Biosanitaria de Granada (ibs. Granada), Spain., Saura C; Vall d'Hebron University Hospital, Barcelona, Vall d'Hebron Institute of Oncology (VHIO), Spain., Rojas B; Hospital Universitario HM Sanchinarro, Madrid, Spain., Bermejo B; Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA, Valencia, Spain.; Medicine Department, Universidad de Valencia, Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain., Ponce Lorenzo J; Dr. Balmis General University Hospital, Alicante Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain., Gion M; Hospital Ruber Internacional, Madrid, Spain.; Hospital Ramon y Cajal, Madrid, Spain., Cortez-Castedo P; Hospital Ruber Internacional, Madrid, Spain., Llabres E; Hospital Universitario Insular de Gran Canarias, Las Palmas de Gran Canaria, Spain., Galve E; Hospital Universitario de Basurto, Bilbao, Spain., Cueva JF; Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain., López A; University Hospital of León, León, Spain., Alonso-Romero JL; Hospital Clínico Universitario Virgen de la Arrixaca, IMIB-Arrixaca, Murcia, Spain., González-Santiago S; Hospital Universitario San Pedro de Alcántara, Cáceres, Spain., Martínez de Dueñas E; Consorcio Hospitalario Provincial of Castellón, Castellón de la Plana, Spain., Ciruelos E; 12 de Octubre University Hospital, Madrid, Spain., Martrat G; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Gener P; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Alcalá-López D; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Sampayo-Cordero M; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Gómez-Peralta F; Hospital General de Segovia, Segovia, Spain., Cortés J; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain.
Publikováno v:
EClinicalMedicine [EClinicalMedicine] 2024 Apr 11; Vol. 71, pp. 102520. Date of Electronic Publication: 2024 Apr 11 (Print Publication: 2024).
Autor:
López González A; Complejo Asistencial Universitario de León, 24071 León, Spain., Del Barco Berrón S; Institut Català d'Oncologia, 17007 Girona, Spain., Grau I; Hospital Son Llatzer, 7198 Palma, Spain., Galan M; Hospital Son Llatzer, 7198 Palma, Spain., Castelo Fernández B; Hospital Universitario La Paz, 28046 Madrid, Spain., Cortés A; Hospital Universitario Ramón y Cajal, 2559 Madrid, Spain., Sánchez Rovira P; Complejo Hospitalario Ciudad de Jaén, 23007 Jaén, Spain., Martinez-Bueno A; Insituto Oncológico Dr. Rosell, Hospital Quiron Dexeus, 08028 Barcelona, Spain., Gonzalez X; Instituto Oncológico Dr. Rosell, Hospital General de Cataluña, 08190 San Cugat del Vallés, Spain.; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, 08017 Barcelona, Spain., García A; Medica Scientia Innovation Research SL (MEDSIR), 08018 Barcelona, Spain., Gener P; Medica Scientia Innovation Research SL (MEDSIR), 08018 Barcelona, Spain., Mina L; Medica Scientia Innovation Research SL (MEDSIR), 08018 Barcelona, Spain., Alcalá-López D; Medica Scientia Innovation Research SL (MEDSIR), 08018 Barcelona, Spain., Sampayo M; Medica Scientia Innovation Research SL (MEDSIR), 08018 Barcelona, Spain., Cortés J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, 08017 Barcelona, Spain.; Medica Scientia Innovation Research SL (MEDSIR), 08018 Barcelona, Spain.; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, 28670 Madrid, Spain., Pérez-Garcia JM; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, 08017 Barcelona, Spain.; Medica Scientia Innovation Research SL (MEDSIR), 08018 Barcelona, Spain., Llombart-Cussac A; Medica Scientia Innovation Research SL (MEDSIR), 08018 Barcelona, Spain.; Arnau de Vilanova Hospital, Universidad Católica de Valencia, 46015 Valencia, Spain., López-Miranda E; Hospital Universitario Ramón y Cajal, 2559 Madrid, Spain.; Medica Scientia Innovation Research SL (MEDSIR), 08018 Barcelona, Spain.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Nov 29; Vol. 14 (23). Date of Electronic Publication: 2022 Nov 29.
Autor:
Jacobs SA; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA. samuel.jacobs@nsabp.org., Robidoux A; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.; Centre hospitalier de l'université de Montréal, Montréal, QC, Canada., Abraham J; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.; Cleveland Clinic, Cleveland, OH, USA., Pérez-Garcia JM; QuironSalud Group, IOB Institute of Oncology, Barcelona, Madrid, Spain.; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain., La Verde N; Present address: ASST Fatebenefratelli Sacco - PO Luigi Sacco, Milan, Italy.; ASST Fatebenefratelli Sacco - PO Fatebenefratelli, Milan, Italy., Orcutt JM; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.; Roper St. Francis Healthcare, Charleston, SC, USA., Cazzaniga ME; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Azienda Ospedaliera San Gerardo, Monza, Italy., Piette F; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Antolín S; Hospital Universitario, Coruña, Spain., Aguirre E; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain., Cortes J; QuironSalud Group, IOB Institute of Oncology, Barcelona, Madrid, Spain.; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain., Llombart-Cussac A; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain., Di Cosimo S; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Fondazione IRCCS Istituto Nazionale di Tumori, Milan, Italy., Kim RS; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA., Feng H; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA., Lipchik C; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA., Lucas PC; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Srinivasan A; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA., Wang Y; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA., Song N; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA., Gavin PG; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA., Balousek AD; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA., Paik S; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.; Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Republic of South Korea., Allegra CJ; Department of Medicine, University of Florida Health, Gainsville, FL, USA., Wolmark N; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.; University of Pittsburgh, Pittsburgh, PA, 15212, USA., Pogue-Geile KL; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2020 Jan 22; Vol. 22 (1), pp. 9. Date of Electronic Publication: 2020 Jan 22.
Autor:
Lopez-Bonet E; Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona 17005, Spain., Buxó M; Girona Biomedical Research Institute (IDIBGI), Girona 17190, Spain., Cuyàs E; Girona Biomedical Research Institute (IDIBGI), Girona 17190, Spain.; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona 08908, Spain., Pernas S; Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona 08908, Spain., Dorca J; Medical Oncology, Catalan Institute of Oncology, Girona 17005, Spain., Álvarez I; Medical Oncology Service, Hospital Universitario Donostia, Donostia-San Sebastián 20014, Spain.; Biodonostia Health Research Institute, Donostia-San Sebastián 20014, Spain., Martínez S; Medical Oncology Department, Hospital de Mataró, Mataró, Barcelona 08304, Spain., Pérez-Garcia JM; IOB Institute of Oncology, Hospital Quirónsalud, Madrid & Barcelona 08023, Spain.; Medica Scientia Innovation Researcher (MedSIR), Barcelona 08007, Spain., Batista-López N; Medical Oncology Service, Hospital Universitario de Canarias, La Laguna, Tenerife 38320, Spain., Rodríguez-Sánchez CA; Medical Oncology Service, Hospital Universitario de Salamanca, Salamanca 37007, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca 37007, Spain., Amillano K; Medical Oncology, Hospital Universitari Sant Joan, Reus 43204, Spain., Domínguez S; Medical Oncology Service, Hospital Universitario Araba, Vitoria-Gasteiz 01009, Spain., Luque M; Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo 33011, Spain., Morilla I; Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona 08908, Spain., Stradella A; Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona 08908, Spain., Viñas G; Medical Oncology, Catalan Institute of Oncology, Girona 17005, Spain., Cortés J; IOB Institute of Oncology, Hospital Quirónsalud, Madrid & Barcelona 08023, Spain.; Medica Scientia Innovation Researcher (MedSIR), Barcelona 08007, Spain.; Vall d'Hebron Institute of Oncology (VHIO), Barcelona 08035, Spain., Oliveras G; Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona 17005, Spain., Meléndez C; Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona 17005, Spain., Castillo L; Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona 17005, Spain., Verdura S; Girona Biomedical Research Institute (IDIBGI), Girona 17190, Spain.; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona 08908, Spain., Brunet J; Medical Oncology, Catalan Institute of Oncology, Girona 17005, Spain.; Hereditary Cancer Programme, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona 08908, Spain.; Hereditary Cancer Programme, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IDIBGI), Girona 17005, Spain., Joven J; Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, IISPV, Rovira i Virgili University, Reus 43204, Spain., Garcia M; Clinical Research Unit, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona 08908, Spain., Saidani S; Unit of Clinical Research, Catalan Institute of Oncology, Girona 17005, Spain., Martin-Castillo B; Unit of Clinical Research, Catalan Institute of Oncology, Girona 17005, Spain., Menendez JA; Girona Biomedical Research Institute (IDIBGI), Girona 17190, Spain.; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona 08908, Spain.
Publikováno v:
Journal of clinical medicine [J Clin Med] 2019 Dec 11; Vol. 8 (12). Date of Electronic Publication: 2019 Dec 11.
Autor:
Jacobs SA; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA. samuel.jacobs@nsabp.org., Robidoux A; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.; Centre hospitalier de l'université de Montréal, Montréal, QC, Canada., Abraham J; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.; Cleveland Clinic, Cleveland, OH, USA., Pérez-Garcia JM; QuironSalud Group, IOB Institute of Oncology, Madrid, Barcelona, Spain.; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain., La Verde N; Present address: ASST Fatebenefratelli Sacco - PO Luigi Sacco, Milan, Italy.; ASST Fatebenefratelli Sacco - PO Fatebenefratelli, Milan, Italy., Orcutt JM; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.; Roper St. Francis Healthcare, Charleston, SC, USA., Cazzaniga ME; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Azienda Ospedaliera San Gerardo, Monza, Italy., Piette F; International Drug Development Institute (IDDI), Louvain-la-Neuve, Belgium., Antolín S; Hospital Universitario, Coruña, Spain., Aguirre E; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain., Cortes J; QuironSalud Group, IOB Institute of Oncology, Madrid, Barcelona, Spain.; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain., Llombart-Cussac A; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain., Di Cosimo S; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Fondazione IRCCS Istituto Nazionale di Tumori, Milan, Italy., Kim RS; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA., Feng H; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA., Lipchik C; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA., Lucas PC; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.; Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA., Srinivasan A; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA., Wang Y; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA., Song N; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA., Gavin PG; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA., Balousek AD; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA., Paik S; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.; Severance Biomedical Science Institute and Department of Medical Oncology, Yonsei University College of Medicine, Seoul, Republic of South Korea., Allegra CJ; Department of Medicine, University of Florida Health, Gainsville, FL, USA., Wolmark N; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.; University of Pittsburgh, Pittsburgh, PA, 15212, USA., Pogue-Geile KL; NSABP Foundation, Inc., Nova Tower 2, Two Allegheny Center - Ste 1200, Pittsburgh, PA, 15212, USA.
Publikováno v:
Breast cancer research : BCR [Breast Cancer Res] 2019 Dec 03; Vol. 21 (1), pp. 133. Date of Electronic Publication: 2019 Dec 03.
Autor:
Cuyàs E; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Fernández-Arroyo S; Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, IISPV, Rovira i Virgili University, Reus, Spain., Buxó M; Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Pernas S; Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Dorca J; Medical Oncology, Catalan Institute of Oncology, Girona, Spain., Álvarez I; Medical Oncology Service, Hospital Universitario Donostia, Donostia-San Sebastián, Spain.; Biodonostia Health Research Institute, Donostia-San Sebastián, Spain., Martínez S; Medical Oncology Department, Hospital de Mataró, Mataró, Barcelona, Spain., Pérez-Garcia JM; IOB Institute of Oncology, Hospital Quirónsalud, Madrid and Barcelona, Spain., Batista-López N; Medical Oncology Service, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain., Rodríguez-Sánchez CA; Medical Oncology Service, Hospital Universitario de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Amillano K; Medical Oncology, Hospital Universitari Sant Joan, Reus, Spain., Domínguez S; Medical Oncology Service, Hospital Universitario Araba, Vitoria-Gasteiz, Spain., Luque M; Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain., Morilla I; Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Stradella A; Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Viñas G; Medical Oncology, Catalan Institute of Oncology, Girona, Spain., Cortés J; IOB Institute of Oncology, Hospital Quirónsalud, Madrid and Barcelona, Spain.; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Verdura S; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Brunet J; Medical Oncology, Catalan Institute of Oncology, Girona, Spain.; Hereditary Cancer Programme, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.; Hereditary Cancer Programme, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IDIBGI), Girona, Spain., López-Bonet E; Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona, Spain., Garcia M; Clinical Research Unit, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain., Saidani S; Unit of Clinical Research, Catalan Institute of Oncology, Girona, Spain., Joven J; Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, IISPV, Rovira i Virgili University, Reus, Spain., Martin-Castillo B; Unit of Clinical Research, Catalan Institute of Oncology, Girona, Spain., Menendez JA; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), Girona, Spain.
Publikováno v:
Aging [Aging (Albany NY)] 2019 May 09; Vol. 11 (9), pp. 2874-2888.
Autor:
Cuyàs E; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Buxó M; Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Ferri Iglesias MJ; Laboratori Clínic Territorial, Parque Hospitalario Martí i Julià, Salt, Spain., Verdura S; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Pernas S; Breast Unit, Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Dorca J; Medical Oncology, Catalan Institute of Oncology, Girona, Spain., Álvarez I; Medical Oncology Service, Hospital Universitario Donostia, Donostia-San Sebastián, Spain.; Biodonostia Health Research Institute, Donostia-San Sebastián, Spain., Martínez S; Medical Oncology Department, Hospital de Mataró, Mataró, Barcelona, Spain., Pérez-Garcia JM; Hospital Quirón, IOB Institute of Oncology, Barcelona, Spain., Batista-López N; Medical Oncology Service, Hospital Universitario de Canarias, San Cristóbal de La Laguna, Spain., Rodríguez-Sánchez CA; Medical Oncology Service, Hospital Universitario de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Amillano K; Medical Oncology, Hospital Universitari Sant Joan, Reus, Spain., Domínguez S; Medical Oncology Service, Hospital Universitario Araba, Vitoria-Gasteiz, Spain., Luque M; Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain., Morilla I; Breast Unit, Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Stradella A; Breast Unit, Department of Medical Oncology, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Viñas G; Medical Oncology, Catalan Institute of Oncology, Girona, Spain., Cortés J; Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain., Joven J; Unitat de Recerca Biomèdica, Hospital Universitari de Sant Joan, IISPV, Rovira i Virgili University, Reus, Spain., Brunet J; Medical Oncology, Catalan Institute of Oncology, Girona, Spain.; Hereditary Cancer Programme, Catalan Institute of Oncology (ICO), Bellvitge Institute for Biomedical Research (IDIBELL), L'Hospitalet del Llobregat, Barcelona, Spain.; Hereditary Cancer Programme, Catalan Institute of Oncology (ICO), Girona Biomedical Research Institute (IDIBGI), Girona, Spain., López-Bonet E; Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona, Spain., Garcia M; Clinical Research Unit, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain., Saidani S; Unit of Clinical Research, Catalan Institute of Oncology, Girona, Spain., Queralt Moles X; Laboratori Clínic Territorial, Parque Hospitalario Martí i Julià, Salt, Spain., Martin-Castillo B; Unit of Clinical Research, Catalan Institute of Oncology, Girona, Spain., Menendez JA; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), Girona, Spain.
Publikováno v:
Frontiers in oncology [Front Oncol] 2019 Mar 28; Vol. 9, pp. 193. Date of Electronic Publication: 2019 Mar 28 (Print Publication: 2019).
Autor:
Martin-Castillo B; Unit of Clinical Research, Catalan Institute of Oncology, Girona, Spain., Pernas S; Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Dorca J; Medical Oncology, Catalan Institute of Oncology, Girona, Spain., Álvarez I; Medical Oncology Service, Hospital Universitario Donostia, Donostia-San Sebastián, Spain.; Biodonostia Health Research Institute, Donostia-San Sebastián, Spain., Martínez S; Medical Oncology Department, Hospital de Mataró, Mataró, Barcelona, Spain., Pérez-Garcia JM; Baselga Institute of Oncology (IOB), Hospital Quirón, Barcelona, Spain., Batista-López N; Medical Oncology Service, Hospital Universitario de Canarias, La Laguna, Tenerife, Spain., Rodríguez-Sánchez CA; Medical Oncology Service, Hospital Universitario de Salamanca, Salamanca, Spain.; Instituto de Investigación Biomédica de Salamanca (IBSAL), Salamanca, Spain., Amillano K; Medical Oncology, Hospital Universitari Sant Joan, Reus, Spain., Domínguez S; Medical Oncology Service, Hospital Universitario Araba, Vitoria-Gasteiz, Spain., Luque M; Department of Medical Oncology, Hospital Universitario Central de Asturias, Oviedo, Spain., Stradella A; Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Morilla I; Department of Medical Oncology, Breast Unit, Catalan Institute of Oncology-Hospital Universitari de Bellvitge-Bellvitge Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain., Viñas G; Medical Oncology, Catalan Institute of Oncology, Girona, Spain., Cortés J; Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain., Cuyàs E; Metabolism and Cancer Group, Girona Biomedical Research Institute, Girona, Spain., Verdura S; Metabolism and Cancer Group, Girona Biomedical Research Institute, Girona, Spain., Fernández-Ochoa Á; Department of Analytical Chemistry, University of Granada, Granada, Spain.; Research and Development of Functional Food Centre (CIDAF), Health Science Technological Park, Granada, Spain., Fernández-Arroyo S; Unitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus, Spain., Segura-Carretero A; Department of Analytical Chemistry, University of Granada, Granada, Spain.; Research and Development of Functional Food Centre (CIDAF), Health Science Technological Park, Granada, Spain., Joven J; Unitat de Recerca Biomèdica, Hospital Universitari Sant Joan, Institut d'Investigació Sanitària Pere Virgili, Universitat Rovira i Virgili, Reus, Spain., Pérez E; Department of Radiology-IDI, Dr. Josep Trueta Hospital of Girona, Girona, Spain., Bosch N; Unit of Clinical Research, Catalan Institute of Oncology, Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Garcia M; Clinical Research Unit, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain., López-Bonet E; Department of Anatomical Pathology, Dr. Josep Trueta Hospital of Girona, Girona, Spain., Saidani S; Unit of Clinical Research, Catalan Institute of Oncology, Girona, Spain.; Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Buxó M; Girona Biomedical Research Institute (IDIBGI), Girona, Spain., Menendez JA; Department of Medical Oncology, Ramón y Cajal University Hospital, Madrid, Spain.; Program Against Cancer Therapeutic Resistance (ProCURE), Metabolism and Cancer Group, Catalan Institute of Oncology, Girona, Spain.
Publikováno v:
Oncotarget [Oncotarget] 2018 Nov 02; Vol. 9 (86), pp. 35687-35704. Date of Electronic Publication: 2018 Nov 02 (Print Publication: 2018).